Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Penicillin V for Prevention of Rheumatic Heart Disease in Children
NCT07798232Phase 3Not yet recruiting
- Sponsor
- Cincinnati Children's Hospital Medical Center
- Start
- Feb 2027
- Primary completion
- Jul 2031
- Countries
- 1
01
Overview
A Phase 3 trial of phenoxymethylpenicillin in rheumatic heart disease (RHD), sponsored by Cincinnati Children's Hospital Medical Center. Planned start Feb 2027; status: not yet recruiting.
02
Drugs
phenoxymethylpenicillin
03
Conditions
rheumatic heart disease (RHD)
Beyond the preview
Go deeper on NCT07798232.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07798232.